Bold initiatives are afoot to transcend the rodent in favor of lab-on-chip and/or organoid models [1], and that’s a good thing. However, persistent reasons return our attention to our little ... More
An Interview with Dr. Kenneth Witwer, PhD | Associate Professor of Molecular and Comparative Pathobiology | Johns Hopkins University School of Medicine Progress in cell and gene therapy is made ... More
An Interview with Dr. Moutih Rafei | Associate Professor, Department of Pharmacology and Physiology | Université de Montréal Progress in cell and gene therapy is made by people who work ... More
Many EV therapeutics will never reach patients — not because the biology fails, but because the manufacturing economics miss the mark. RoosterBio builds downstream processing (DSP) platforms designed from day ... More
RoosterBio presents seven posters across ISEV 2026 (San Juan), ISCT 2026 (Dublin), and ISSCR 2026 (Montréal), covering scalable MSC-EV upstream production, GMP-compatible downstream processing, and orthogonal potency analytics including CD73 ... More
Revisiting “Identify & Define Your Cell Therapy’s Biomanufacturing Approach for Critical Process Parameters (CPPs)” by Josephine Lembong, PhD [1] One of the most recycled mantras in cell and gene therapy manufacturing ... More
“There is nothing in the intellect that was not first in the sense”. — Aristotle With a nod to Wise Old Aristotle, we scientists prefer to use sharpened senses and ... More
“Form follows function” is a familiar phrase. Yet in extracellular vesicle (EV) translational science, the relationship is reciprocal, not unidirectional. What EVs and/or exosomes contain, and how they are structured, ... More
Like the legend of the phoenix All ends with beginnings What keeps the planet spinning The force from the beginning – Daft Punk, featuring Pharrell Williams & Nile Rodgers Good ... More
Listen to this Blog: Your browser does not support audio. Author’s note: This is a follow-up to a previous blog in 2023, where I interviewed an earnest large language ... More
